BioAge Labs Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for BioAge Labs, Inc. (BIOA) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022
Period EndingDec 2024Dec 2023Dec 2022
Operating Activities
Net Income-71.11-63.85-39.72
Depreciation & Amortization0.170.160.13
Stock Based Compensation6.983.022.54
Change in Working Capital11.186.710.80
Change in Accounts Payable0.01-0.390.99
Change in Other Working Capital11.176.510.10
Other Operating Activities1.276.510.10
Net Cash from Operating Activities-51.52-37.36-36.18
Investing Activities
Capital Expenditures-0.37-0.17-0.10
Purchases of Investments0.00-0.100.00
Net Cash from Investing Activities-0.37-0.27-0.10
Financing Activities
Debt Repayment-6.00-1.000.00
Common Stock Issued221.620.000.04
Other Financing Activities165.58-0.06-0.05
Net Cash from Financing Activities381.2034.942.50
Summary
Effect of Forex Changes on Cash0.080.000.25
Net Change in Cash329.39-2.69-33.79
Cash at Beginning of Period24.9627.6461.18
Cash at End of Period354.3524.9627.64
Free Cash Flow-51.89-37.53-36.28
Supplemental Disclosures
Interest Paid1.421.160.13